Market Tracker

05/25 5:16pm ET

Arbutus Biopharma Corp (NASDAQ:ABUS)

3.50
Delayed Data
As of 3:59pm ET
 -0.15 / -4.11%
Today’s Change
2.35
Today|||52-Week Range
4.49
+42.86%
Year-to-Date
No recent news for Arbutus Biopharma Corp.

Today’s Trading

Previous close3.65
Today’s open3.62
Day’s range3.50 - 3.70
Volume85,575
Average volume (3 months)198,147
Market cap$200.8M
Dividend yield--
Data as of 3:59pm ET, 05/25/2017

Growth & Valuation

Earnings growth (last year)-440.30%
Earnings growth (this year)+78.63%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-94.01%
P/E ratio--
Price/Sales87.21
Price/Book0.99

Competitors

 Today’s
change
Today’s
% change
CORICorium International...-0.02-0.29%
URGNUrogen Pharma Ltd-0.29-1.55%
MDGLMadrigal Pharmaceuti...+0.28+1.81%
CEMPCempra Inc+0.05+1.32%
Data as of 3:59pm ET, 05/25/2017

Financials

Next reporting dateAugust 4, 2017
EPS forecast (this quarter)-$0.42
Annual revenue (last year)$1.5M
Annual profit (last year)-$384.2M
Net profit margin-25,765.53%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark J. Murray
Chief Financial Officer &
Executive Vice President
Bruce G. Cousins
Corporate headquarters
Burnaby, British Columbia

Forecasts